Dr. Fabio Iwamoto, MD
Claim this profileColumbia University Medical Center
Area of expertise
Glioblastoma
Fabio Iwamoto, MD has run 12 trials for Glioblastoma. Some of their research focus areas include:
Brain Tumor
Fabio Iwamoto, MD has run 6 trials for Brain Tumor. Some of their research focus areas include:
Affiliated Hospitals
Columbia University Medical Center
Columbia University
Clinical Trials Fabio Iwamoto, MD is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting
2 awards
Phase 3
4 criteria
Safusidenib
for Brain Cancer
This trial is testing a new oral medication called safusidenib for patients with certain types of brain tumors that have not responded to other treatments. The drug works by targeting a specific gene mutation to slow down tumor growth. The study will evaluate the safety and effectiveness of different doses of the medication.
Recruiting
0 awards
Phase 2
20 criteria
More about Fabio Iwamoto, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Fabio Iwamoto, MD has experience with
- Temozolomide
- Nivolumab
- Pembrolizumab
- Placebo
- Triamcinolone Acetonide
- Clindamycin Phosphate
Breakdown of trials Fabio Iwamoto, MD has run
Glioblastoma
Brain Tumor
Relapse
Follicular Lymphoma
Central Nervous System Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fabio Iwamoto, MD specialize in?
Fabio Iwamoto, MD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved Stage IV patients, or patients who are BRAF positive.
Is Fabio Iwamoto, MD currently recruiting for clinical trials?
Yes, Fabio Iwamoto, MD is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Fabio Iwamoto, MD has studied deeply?
Yes, Fabio Iwamoto, MD has studied treatments such as Temozolomide, Nivolumab, Pembrolizumab.
What is the best way to schedule an appointment with Fabio Iwamoto, MD?
Apply for one of the trials that Fabio Iwamoto, MD is conducting.
What is the office address of Fabio Iwamoto, MD?
The office of Fabio Iwamoto, MD is located at: Columbia University Medical Center, New York, New York 10032 United States. This is the address for their practice at the Columbia University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.